基于的癌症免疫疗法后的促炎性反应
Hanie Mahaki1, Hassan Ravari1, Gholamhossein Kazemzadeh1
1Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
治疗性类疫苗旨在通过促进CD8+T细胞免疫反应来预防癌症. 这些疫苗被认为可以增加IFN-γ,TNF-α,IL-2和IL-12等关键细胞因子,增强抗瘤活性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 疫苗学 疫苗学 疫苗学
背景情况:
- 治疗性疫苗注射诱导免疫反应对瘤抗原进行癌症预防.
- 瘤相关抗原 (TAA) 或瘤特异性是由MHC分子向T细胞呈现的.
- CD8+ T 淋巴细胞是癌症免疫治疗中的关键调解者,用于瘤抑制.
研究的目的:
- 审查基于的疫苗对针对性瘤抗原的CD8+T细胞中细胞因子产生的影响.
- 在癌症免疫治疗的背景下探索CD8+T细胞激活和功能障碍的机制.
主要方法:
- 在体内和体外研究数据的审查.
- 对调查基于的疫苗疗效的研究进行分析.
- 检查T细胞激活通路和细胞因子概况.
主要成果:
- 基于的疫苗被假设可以增加来自CD8+T细胞的IFN-γ,TNF-α,IL-2和IL-12的分泌.
- 据信与树突细胞 (DCs) 的相互作用可以刺激免疫系统.
- 有证据表明,增强的CTL (细胞毒性T淋巴细胞) 线分泌这些细胞因子.
结论:
- 基于的疫苗通过调节CD8+T细胞细胞因子配置文件,显示出增强抗瘤免疫力的潜力.
- 对CTL激活和功能障碍机制的进一步研究是有必要的.
- 审查的数据支持类疫苗在促进癌症免疫疗法的关键促炎细胞因子方面的作用.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
相关概念视频
Tumor Immunotherapy
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
